Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$508 Mln
P/E Ratio
--
P/B Ratio
1.01
Industry P/E
--
Debt to Equity
0.36
ROE
-0.23 %
ROCE
-17.5 %
Div. Yield
0 %
Book Value
13
EPS
-3.2
CFO
$309.64 Mln
EBITDA
$189.47 Mln
Net Profit
$-223.72 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Orthofix Medical Inc. (DE) (OFIX)
| -24.74 | -20.99 | -28.43 | 0.31 | -27.76 | -16.12 | -9.69 |
|
BSE Sensex*
| 2.39 | 4.18 | 4.86 | 8.78 | 11.89 | 20.62 | 11.13 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Orthofix Medical Inc. (DE) (OFIX)
| 29.25 | -34.34 | -33.97 | -27.66 | -6.93 | -12.02 | -4.02 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 15.28 | 10,289.47 | 14.38 | 12.69 | |
| 70.06 | 9,544.04 | 92.52 | 2.52 | |
| 152.07 | 8,064.21 | -- | -25.23 | |
| 277.22 | 10,728.90 | 773.26 | 1.2 |
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine... segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas. Address: 3451 Plano Parkway, Lewisville, TX, United States, 75056 Read more
President of Global Orthopedics
Ms. Kimberley A. Elting
President of Global Orthopedics
Ms. Kimberley A. Elting
Headquarters
Lewisville, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Orthofix Medical Inc (DE) (OFIX) stood at $ 893 Mln as on 31-Dec-24
The share price of Orthofix Medical Inc (DE) (OFIX) is $13.14 (NASDAQ) as of 22-Apr-2025 16:00 EDT. Orthofix Medical Inc (DE) (OFIX) has given a return of -27.76% in the last 3 years.
Orthofix Medical Inc (DE) (OFIX) has a market capitalisation of $ 508 Mln as on 21-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Orthofix Medical Inc (DE) (OFIX) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Orthofix Medical Inc (DE) (OFIX) and enter the required number of quantities and click on buy to purchase the shares of Orthofix Medical Inc (DE) (OFIX).
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas. Address: 3451 Plano Parkway, Lewisville, TX, United States, 75056
The CEO & director of Ms. Kimberley A. Elting. is Orthofix Medical Inc (DE) (OFIX), and CFO & Sr. VP is Ms. Kimberley A. Elting.
There is no promoter pledging in Orthofix Medical Inc (DE) (OFIX).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,070
|
|
|
1,049
|
|
|
978
|
|
|
820
|
| Orthofix Medical Inc. (DE) (OFIX) | Ratios |
|---|---|
|
Return on equity(%)
|
-22.48
|
|
Operating margin(%)
|
-11.79
|
|
Net Margin(%)
|
-15.49
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Orthofix Medical Inc (DE) (OFIX) was $0 Mln.
$0.22
(
